The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

NCT00640640 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Neovascular Age Related Macular Degeneration

Interventions

DEVICE: Pascal Dynamic Contour Tonometer
DRUG: Ranibizumab
DRUG: Bevacizumab

Sponsor

Sheba Medical Center

Collaborators

[object Object]